Two-year Surveillance of Rotavirus Genotypes Causing Acute Diarrhea in Children Younger Than 5 Years Requiring Emergency Room (ER) and Hospital Admission in Chile
NCT00895492 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 967
Last updated 2014-05-01
Summary
The purpose of this study is to prospectively determine the rotavirus VP7/VP4 genotypes associated with moderate to severe disease (requiring emergency room (ER) consult or hospitalization) in a large public hospital from Valparaiso and another from Santiago.
Conditions
- Acute Diarrheal Disease
- Rotavirus Infection
Sponsors & Collaborators
- collaborator INDUSTRY
-
University of Chile
lead OTHER
Principal Investigators
-
Miguel L O'Ryan, MD · Microbiology and Micology Program, Faculty of Medicine, University of Chile
Eligibility
- Min Age
- 1 Month
- Max Age
- 5 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-05-31
- Primary Completion
- 2010-03-31
- Completion
- 2010-04-30
Countries
- Chile
Study Locations
More Related Trials
-
Impact of Rotavirus Vaccination on Hospital Pressures at a Large Paediatric Hospital in the UK: an Ecological Study
NCT03271593 ·Status: COMPLETED
-
Canadian Rotavirus Surveillance Through the Immunization Monitoring Program Active (IMPACT)
NCT01633190 ·Status: UNKNOWN
-
Effectiveness of Monovalent Rotavirus Vaccine (RV1)
NCT01871038 ·Status: COMPLETED
-
Surveillance of Rotavirus Gastroenteritis in Children <5 Years
NCT01363726 ·Status: UNKNOWN
-
Impact of Systematic Infants Vaccination Against Rotavirus on Gastroenteritis Hospitalization: a Prospective Study in Brest District, France.
NCT00740935 ·Status: COMPLETED ·Phase: PHASE4
-
Glycan Attachment Specificity, Toward ROtavirus Vaccine IMprovement GASTROVIMc (Clinical Investigation)
NCT02902445 ·Status: COMPLETED
-
The Efficacy of Oral Rotavirus Vaccine 116E (ROTAVAC 5D) in Chilean Infants
NCT06200844 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Improving Rotavirus Vaccine Immune Response
NCT01825109 ·Status: COMPLETED ·Phase: PHASE3
-
Surveillance Study to Estimate the Proportion of Rotavirus Gastroenteritis in Children < 5 Years of Age in Romania
NCT01253967 ·Status: COMPLETED
-
Potential Mechanisms for Intussusception After Rotavirus Vaccine-Pilot Study
NCT02542462 ·Status: COMPLETED ·Phase: PHASE4
-
Response to Rotavirus Vaccine in Infants in Ho Chi Minh City in Vietnam
NCT03587389 ·Status: COMPLETED ·Phase: PHASE4
-
Epidemiological, Observational and Post Marketing Study of Rotarix™ in Children With Severe Gastroenteritis in Belgium
NCT01339221 ·Status: COMPLETED
-
Impact of Rotavirus Vaccine Introduction for South Australian Children
NCT01472575 ·Status: UNKNOWN
-
The Epidemiology and Etiology of Acute Gastroenteritis Among Estonian Children After Introduction of Rotavirus Vaccines
NCT02662543 ·Status: UNKNOWN
-
ROTATEQ Reexamination Study (V260-037)
NCT01074242 ·Status: COMPLETED
-
Efficacy Study of Nitazoxanide Suspension in the Treatment of Rotavirus Disease in Children
NCT01328925 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Immunogenicity of Norovirus GI.1/GII.4 Bivalent Virus-Like Particle (VLP) Vaccine in Children
NCT02153112 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of the Immunogenicity, Tolerability, and Safety of a New Formulation of RotaTeq™ in Infants (V260-035)
NCT01600092 ·Status: COMPLETED ·Phase: PHASE3
-
Effectiveness of RotarixTM Vaccine in Children Aged Between 12 Weeks to < 5 Years, Hospitalised for Severe Gastroenteritis
NCT01978223 ·Status: WITHDRAWN
-
Number of Rotavirus (RV) Related Hospitalizations in Belgium - Season 2010-2011
NCT01563159 ·Status: COMPLETED
-
A Study to Estimate the Occurrence of Rotavirus Gastroenteritis in Children < 5 Years of Age, in Bulgaria and Latvia
NCT01733849 ·Status: COMPLETED
-
Human Challenge With Live-attenuated Rotavirus to Assess Next-generation Rotavirus Vaccines in Africa
NCT04658914 ·Status: COMPLETED ·Phase: PHASE2
-
Pilot Study of the Rotavirus Vaccine in Infants With Intestinal Failure
NCT00995813 ·Status: COMPLETED ·Phase: PHASE4
-
Observational Study on Rotavirus Gastroenteritis Epidemiology, Impact of Lyophilised vs. Liquid Formulation of Rotarix™
NCT01435967 ·Status: COMPLETED
-
Year 3 Extension for Efficacy Follow-up in Subjects Vaccinated in Studies Rota-028, 029 or 030 (NCT00197210)
NCT00329745 ·Status: COMPLETED ·Phase: PHASE3